310 related articles for article (PubMed ID: 19046432)
1. Retinoid X receptor and peroxisome proliferator-activated receptor-gamma agonists cooperate to inhibit matrix metalloproteinase gene expression.
Burrage PS; Schmucker AC; Ren Y; Sporn MB; Brinckerhoff CE
Arthritis Res Ther; 2008; 10(6):R139. PubMed ID: 19046432
[TBL] [Abstract][Full Text] [Related]
2. Regulation of matrix metalloproteinase gene expression by a retinoid X receptor-specific ligand.
Burrage PS; Huntington JT; Sporn MB; Brinckerhoff CE
Arthritis Rheum; 2007 Mar; 56(3):892-904. PubMed ID: 17328062
[TBL] [Abstract][Full Text] [Related]
3. Transactivation of the PPAR-responsive enhancer module in chemopreventive glutathione S-transferase gene by the peroxisome proliferator-activated receptor-gamma and retinoid X receptor heterodimer.
Park EY; Cho IJ; Kim SG
Cancer Res; 2004 May; 64(10):3701-13. PubMed ID: 15150131
[TBL] [Abstract][Full Text] [Related]
4. A peroxisome proliferator-activated receptor gamma-retinoid X receptor heterodimer physically interacts with the transcriptional activator PAX6 to inhibit glucagon gene transcription.
Krätzner R; Fröhlich F; Lepler K; Schröder M; Röher K; Dickel C; Tzvetkov MV; Quentin T; Oetjen E; Knepel W
Mol Pharmacol; 2008 Feb; 73(2):509-17. PubMed ID: 17962386
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor gamma and retinoid X receptor transcription factors are released from activated human platelets and shed in microparticles.
Ray DM; Spinelli SL; Pollock SJ; Murant TI; O'Brien JJ; Blumberg N; Francis CW; Taubman MB; Phipps RP
Thromb Haemost; 2008 Jan; 99(1):86-95. PubMed ID: 18217139
[TBL] [Abstract][Full Text] [Related]
6. Ligand Activity of Group 15 Compounds Possessing Triphenyl Substituent for the RXR and PPARγ Nuclear Receptors.
Hiromori Y; Ido A; Aoki A; Kimura T; Nagase H; Nakanishi T
Biol Pharm Bull; 2016; 39(10):1596-1603. PubMed ID: 27725436
[TBL] [Abstract][Full Text] [Related]
7. Protection against influenza-induced Acute Lung Injury (ALI) by enhanced induction of M2a macrophages: possible role of PPARγ/RXR ligands in IL-4-induced M2a macrophage differentiation.
Gopalakrishnan A; Joseph J; Shirey KA; Keegan AD; Boukhvalova MS; Vogel SN; Blanco JCG
Front Immunol; 2022; 13():968336. PubMed ID: 36052067
[TBL] [Abstract][Full Text] [Related]
8. Biological characterization of a heterodimer-selective retinoid X receptor modulator: potential benefits for the treatment of type 2 diabetes.
Leibowitz MD; Ardecky RJ; Boehm MF; Broderick CL; Carfagna MA; Crombie DL; D'Arrigo J; Etgen GJ; Faul MM; Grese TA; Havel H; Hein NI; Heyman RA; Jolley D; Klausing K; Liu S; Mais DE; Mapes CM; Marschke KB; Michellys PY; Montrose-Rafizadeh C; Ogilvie KM; Pascual B; Rungta D; Tyhonas JS; Urcan MS; Wardlow M; Yumibe N; Reifel-Miller A
Endocrinology; 2006 Feb; 147(2):1044-53. PubMed ID: 16269450
[TBL] [Abstract][Full Text] [Related]
9. Combination of peroxisome proliferator-activated receptor gamma and retinoid X receptor agonists induces sodium/iodide symporter expression and inhibits cell growth of human thyroid cancer cells.
Chen JY; Wang JJ; Lee HC; Chi CW; Lee CH; Hsu YC
J Chin Med Assoc; 2020 Oct; 83(10):923-930. PubMed ID: 33009242
[TBL] [Abstract][Full Text] [Related]
10. Enhanced effects of PPARgamma ligands and RXR selective retinoids in combination to inhibit migration and invasiveness in cancer cells.
Papi A; Rocchi P; Ferreri AM; Guerra F; Orlandi M
Oncol Rep; 2009 Apr; 21(4):1083-9. PubMed ID: 19288012
[TBL] [Abstract][Full Text] [Related]
11. A naturally occurring rexinoid, honokiol, can serve as a regulator of various retinoid x receptor heterodimers.
Kotani H; Tanabe H; Mizukami H; Amagaya S; Inoue M
Biol Pharm Bull; 2012; 35(1):1-9. PubMed ID: 22223330
[TBL] [Abstract][Full Text] [Related]
12. Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3.
Magenta G; Borenstein X; Rolando R; Jasnis MA
BMC Cancer; 2008 Feb; 8():47. PubMed ID: 18261208
[TBL] [Abstract][Full Text] [Related]
13. Combined low doses of PPARgamma and RXR ligands trigger an intrinsic apoptotic pathway in human breast cancer cells.
Bonofiglio D; Cione E; Qi H; Pingitore A; Perri M; Catalano S; Vizza D; Panno ML; Genchi G; Fuqua SA; Andò S
Am J Pathol; 2009 Sep; 175(3):1270-80. PubMed ID: 19644018
[TBL] [Abstract][Full Text] [Related]
14. 9-cis-Retinoic acid (9cRA), a retinoid X receptor (RXR) ligand, exerts immunosuppressive effects on dendritic cells by RXR-dependent activation: inhibition of peroxisome proliferator-activated receptor gamma blocks some of the 9cRA activities, and precludes them to mature phenotype development.
Zapata-Gonzalez F; Rueda F; Petriz J; Domingo P; Villarroya F; de Madariaga A; Domingo JC
J Immunol; 2007 May; 178(10):6130-9. PubMed ID: 17475839
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies.
Desreumaux P; Dubuquoy L; Nutten S; Peuchmaur M; Englaro W; Schoonjans K; Derijard B; Desvergne B; Wahli W; Chambon P; Leibowitz MD; Colombel JF; Auwerx J
J Exp Med; 2001 Apr; 193(7):827-38. PubMed ID: 11283155
[TBL] [Abstract][Full Text] [Related]
16. Involvement of glucocorticoid receptor activation on anti-inflammatory effect induced by peroxisome proliferator-activated receptor γ agonist in mice.
Yamamoto A; Kakuta H; Sugimoto Y
Int Immunopharmacol; 2014 Sep; 22(1):204-8. PubMed ID: 24975659
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator--activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes.
Fahmi H; Di Battista JA; Pelletier JP; Mineau F; Ranger P; Martel-Pelletier J
Arthritis Rheum; 2001 Mar; 44(3):595-607. PubMed ID: 11263774
[TBL] [Abstract][Full Text] [Related]
18. Derivation of a retinoid X receptor scaffold from peroxisome proliferator-activated receptor gamma ligand 1-Di(1H-indol-3-yl)methyl-4-trifluoromethylbenzene.
Dawson MI; Ye M; Cao X; Farhana L; Hu QY; Zhao Y; Xu LP; Kiselyuk A; Correa RG; Yang L; Hou T; Reed JC; Itkin-Ansari P; Levine F; Sanner MF; Fontana JA; Zhang XK
ChemMedChem; 2009 Jul; 4(7):1106-19. PubMed ID: 19378296
[TBL] [Abstract][Full Text] [Related]
19. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
[TBL] [Abstract][Full Text] [Related]
20. Assessment of total, ligand-induced peroxisome proliferator activated receptor γ ligand activity in serum.
Edwards L; Watt J; Webster TF; Schlezinger JJ
Environ Health; 2019 May; 18(1):45. PubMed ID: 31072366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
